[
  {
    "ts": null,
    "headline": "Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade",
    "summary": "Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, margins, and shareholder returns.",
    "url": "https://finnhub.io/api/news?id=ee5b2e1a8410b314a83eba8754dc1afd39c741c211da7b26aa3050a0268ca84c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748215455,
      "headline": "Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade",
      "id": 134697099,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2191975796/image_2191975796.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, margins, and shareholder returns.",
      "url": "https://finnhub.io/api/news?id=ee5b2e1a8410b314a83eba8754dc1afd39c741c211da7b26aa3050a0268ca84c"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of May 25",
    "summary": "Dividend Champion, Contender, And Challenger Highlights: Week Of May 25",
    "url": "https://finnhub.io/api/news?id=6cfeee67c0b989629a091e09a9db5c66c443017f3e7f77411cf38831e1a74e18",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748138423,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of May 25",
      "id": 134691666,
      "image": "",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=6cfeee67c0b989629a091e09a9db5c66c443017f3e7f77411cf38831e1a74e18"
    }
  }
]